Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes.
10.4093/dmj.2016.40.3.202
- Author:
Seon Ah CHA
1
;
Jae Seung YUN
;
Tae Seok LIM
;
Seawon HWANG
;
Eun Jung YIM
;
Ki Ho SONG
;
Ki Dong YOO
;
Yong Moon PARK
;
Yu Bae AHN
;
Seung Hyun KO
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. kosh@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Cardiovascular diseases;
Diabetes mellitus, type 2;
Mortality;
Severe hypoglycemia
- MeSH:
Cardiovascular Diseases;
Diabetes Mellitus, Type 2;
Diabetic Nephropathies;
Follow-Up Studies;
Hemoglobin A, Glycosylated;
Humans;
Hypertension;
Hypoglycemia*;
Insulin;
Mortality*
- From:Diabetes & Metabolism Journal
2016;40(3):202-210
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: We investigated the association between severe hypoglycemia (SH) and the risk of cardiovascular (CV) or all-cause mortality in patients with type 2 diabetes. METHODS: The study included 1,260 patients aged 25 to 75 years with type 2 diabetes from the Vincent Type 2 Diabetes Resgistry (VDR), who consecutively enrolled (n=1,260) from January 2000 to December 2010 and were followed up until May 2015 with a median follow-up time of 10.4 years. Primary outcomes were death from any cause or CV death. We investigated the association between the CV or all-cause mortality and various covariates using Cox proportional hazards regression analysis. RESULTS: Among the 906 participants (71.9%) who completed follow-up, 85 patients (9.4%) had at least one episode of SH, and 86 patients (9.5%) died (9.1 per 1,000 patient-years). Patients who had died were older, had a longer duration of diabetes and hypertension, received more insulin, and had more diabetic microvascular complications at baseline, as compared with surviving patients. The experience of SH was significantly associated with an increased risk of all-cause mortality (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.39 to 5.02; P=0.003) and CV mortality (HR, 6.34; 95% CI, 2.02 to 19.87; P=0.002) after adjusting for sex, age, diabetic duration, hypertension, mean glycosylated hemoglobin levels, diabetic nephropathy, lipid profiles, and insulin use. CONCLUSION: We found a strong association between SH and increased risk of all-cause and CV mortality in patients with type 2 diabetes.
